Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Valbenazine Improves Quality of Life, Functionality, and Movement Severity in Patients With Tardive Dyskinesia: Findings From the KINECT-PRO™ Study.
Journal: CNS spectrums
Published: August 10, 2026
Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report.
Journal: The international journal of neuropsychopharmacology
Published: October 21, 2025
The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus Statement.
Journal: Neuropsychiatric disease and treatment
Published: August 22, 2025
Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trial.
Journal: Journal of affective disorders
Published: July 24, 2025
Pimavanserin safety in adult and elderly patients with neuropsychiatric symptoms related to neurodegenerative disease: An open-label extension study.
Journal: Journal of Alzheimer's disease : JAD
Published: June 16, 2025
Management of Parkinson's disease psychosis: first-line antipsychotic selection and rationale for continuing, combining, or switching.
Journal: Expert opinion on pharmacotherapy
Published: March 26, 2025
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial.
Journal: Brain stimulation
Published: September 20, 2024
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trial.
Journal: Brain stimulation
Published: September 20, 2024
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.
Journal: Brain stimulation
Published: January 04, 2024
Importance of achieving rapid treatment response in major depressive disorder.
Journal: CNS spectrums
Published: March 26, 2023
Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: January 30, 2023
An Open-Label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults with Parkinson's Disease and Depression.
Journal: Journal of Parkinson's disease
Published: August 18, 2020
Last Updated: 09/26/2026